VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing of Listeria spp
Dr. Mark Miller Joins bioMérieux as Chief Medical Officer
World-leading expert on infectious disease prevention and control to enhance medical value of bioMérieux’s solutions
Shipment Delays in the Mid Atlantic and North East Due to Hurricane Sandy
Due to the the impact of hurricane Sandy in the mid atlantic and the north east, product delivery services by national carriers has been interrupted.
bioMérieux Industry Announces AOAC Approval for the VIDAS® Capylobacter (CAM) Assay and Campy Food Agar Enumeration Method
Comprehensive Solution Rapidly Detects and Enumerates Campylobacter in Foods
Thermo Fisher Scientific and bioMérieux Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker
Procalcitonin (PCT) Immunoassay is Sustained on VIDAS® Instruments
bioMérieux - First-Half Results at June 30, 2012
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met today to approve the consolidated financial statements for the six months ended June 30, 2012.
bioMérieux to Demonstrate "Microbiology Pathway: From Sample to Decision" at the 2012 International Association for Food Protection (IAFP)
Symposium to feature Food Industry leaders’ discussion: “Increasing the Efficiency of Producing, Monitoring and Distributing Foods - How Your Microbiology Testing Program Can Help”
bioMérieux Industry Announces New Smasher™ XL High Performance Blender/Homogenizer for Large Sample Preparation
High Capacity Blender Prepares Large Samples up to 375g, Improving Productivity in Food Laboratories.
bioMérieux - First-Half 2012 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2012.
bioMérieux Presents 2012 Sonnenwirth Award for Leadership in Clinical Microbiology to Susan Sharp, Ph.D.
Annual Sonnenwirth Award recognizes a distinguished microbiologist for the promotion of innovation in clinical laboratory science, dedication to ASM, and the advancement of clinical microbiology as a profession